Have a feature idea you'd love to see implemented?
Let us know!
ELAN Elanco Animal Health Inc
Price (delayed)
$12.39
Market cap
$6.12B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.55
Enterprise value
$11.38B
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company,
Highlights
The debt is down by 6% year-on-year
The company's EPS rose by 3.8% QoQ
ELAN's equity is down by 20% YoY
The quick ratio has contracted by 12% YoY and by 6% from the previous quarter
Key stats
What are the main financial stats of ELAN
Market
Valuations
Earnings
Shares outstanding
494.33M
Market cap
$6.12B
Enterprise value
$11.38B
Price to book (P/B)
1.03
Price to sales (P/S)
1.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.53
Revenue
$4.49B
EBIT
-$974M
EBITDA
-$302M
Free cash flow
$491M
Per share
Balance sheet
Liquidity
EPS
-$2.55
Free cash flow per share
$0.99
Book value per share
$12.02
Revenue per share
$9.09
TBVPS
$10.69
Total assets
$13.76B
Total liabilities
$7.82B
Debt
$5.68B
Equity
$5.94B
Working capital
$2.64B
Debt to equity
0.96
Current ratio
2.93
Quick ratio
1.09
Net debt/EBITDA
-17.42
Margins
Efficiency
Dividend
EBITDA margin
-6.7%
Gross margin
55.2%
Net margin
-27.9%
Operating margin
-21.7%
Return on assets
-8.9%
Return on equity
-20.6%
Return on invested capital
-10.6%
Return on capital employed
-7.9%
Return on sales
-21.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ELAN stock price
How has the Elanco Animal Health stock price performed over time
Intraday
-0.96%
1 week
-3.43%
1 month
-10.73%
1 year
36.45%
YTD
-16.85%
QTD
-15.66%
Financial performance
How have Elanco Animal Health's revenue and profit performed over time
Revenue
$4.49B
Gross profit
$2.48B
Operating income
-$974M
Net income
-$1.26B
Gross margin
55.2%
Net margin
-27.9%
The company's operating margin rose by 6% QoQ
The net margin is up by 6% since the previous quarter
The gross margin has contracted by 3.7% YoY
Elanco Animal Health's net income has increased by 3.6% from the previous quarter
Growth
What is Elanco Animal Health's growth rate over time
Valuation
What is Elanco Animal Health stock price valuation
P/E
N/A
P/B
1.03
P/S
1.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.53
The company's EPS rose by 3.8% QoQ
The price to book (P/B) is 26% lower than the 5-year quarterly average of 1.4 and 14% lower than the last 4 quarters average of 1.2
ELAN's equity is down by 20% YoY
ELAN's P/S is 46% below its 5-year quarterly average of 2.5 and 15% below its last 4 quarters average of 1.6
Elanco Animal Health's revenue has increased by 3.9% YoY and by 2.9% from the previous quarter
Efficiency
How efficient is Elanco Animal Health business performance
The company's return on sales rose by 6% QoQ
Elanco Animal Health's ROIC has increased by 2.8% from the previous quarter
Dividends
What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ELAN.
Financial health
How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 76% higher than its total liabilities
Elanco Animal Health's total assets has decreased by 13% YoY
The quick ratio has contracted by 12% YoY and by 6% from the previous quarter
The debt is 4.5% smaller than the equity
ELAN's equity is down by 20% YoY
The debt to equity has increased by 17% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.